Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

TKT product advances toward the clinic

Jan. 29, 1997

Japanese researchers isolate novel ACAT inhibitor

Jan. 29, 1997

GHRP mimetics reported by Pfizer for treatment of osteoporosis

Jan. 29, 1997

Hypocholesterolemic activity of raloxifene established in rats

Jan. 28, 1997

GRF analogues developed for growth hormone deficiencies

Jan. 28, 1997

Nisshin Flour Milling claims antidiabetic compounds

Jan. 28, 1997

Therapeutically active PTH derivatives reported by Takeda

Jan. 27, 1997

Phase I trials begin for Fabry's disease

Jan. 24, 1997

Muse licensed to Janssen for certain markets

Jan. 24, 1997

GelTex reports CholestaGel phase II data

Jan. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...